Indications
Yentreve is indicated for women for the treatment of moderate to severe stress urinary incontinence (SUI).
Composition
- Active substance
- duloxetine hydrochloride
- International name (INN)
- duloxetine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Yentreve
- Active substance
- duloxetine hydrochloride
- ATC code
- N06AX21
- Group
- Nervous system
- Therapeutic area
- Urinary Incontinence, Stress
- Marketing authorisation holder
- Eli Lilly Nederland B.V.
- Status
- Authorised